PENTAX-MEDICAL
PENTAX Medical, a division of HOYA Corporation, announced the appointment of Dr. Hudson Garrett to the position of Global Chief Clinical Officer. In this executive role, Hudson Garrett is responsible for leading all PENTAX Medical clinical related activities globally.
PENTAX Medical has decided to establish this role to accelerate its focus on delivering clinically relevant products to improve quality and standard of patient care. Dr. Garrett’s expertise and experiences in infection control in various medical institutions will enforce its commitment to minimize risk of infection and cross contamination. It will also further develop the scientific community by investing in professional education to raise the bar of patient care.
“Hudson joins PENTAX Medical with valuable expertise gained from various segments of the medical field on the vender and provider side”, said David Woods, Global CMO of PENTAX Medical, HOYA Group. “He has the credentials and expertise to oversee PENTAX Medical’s clinical activities by working with our customers, industry partners and internal team members to develop and deliver high quality products cost effectively with attention to provider and patient satisfaction.”
“I am committed to make the best use of my clinical background in infection prevention, control and clinical affairs to position PENTAX Medical as a thought leader in medical device hygiene, evidence-based clinical education, and clinical research”, Dr. Garrett says. “I am committed to ensuring we clearly demonstrate the PENTAX Medical ethos of offering clinically advanced evidence-based products.”
Dr. Garrett holds a Bachelor of Science degree in biology/chemistry and nursing, dual masters in nursing and public health, a post-masters certificate as a family nurse practitioner, a post-masters certificate in infection prevention and control, and a PhD in healthcare administration and policy. He is a graduate of the Johns Hopkins Fellowship in Infection Control and Hospital Epidemiology, and was honored as a Who’s Who in Infection Control Today Magazine in 2013.
About PENTAX Medical
PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. For more information, please visit: www.pentaxmedical.com .
View source version on businesswire.com: http://www.businesswire.com/news/home/20160623006517/en/
Contact:
Kaori Kawashima
GM, Corporate Communications & Product Branding
PENTAX
Medical
HOYA Corporation
Mobile phone: +81-80-4794-5842
E-mail:
kaori.kawashima@pentaxmedical.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LIBERTEX29.3.2024 06:26:33 CET | Press release
PAN Finance Names Libertex ‘Global CFD Broker of the Year’
MIDEA-GROUP29.3.2024 02:40:30 CET | Press release
Midea Group releases its first-ever ESG brand story with an unexpected VIP visit highlighting its commitment to sustainability.
NY-DC-ADMINISTRATION28.3.2024 21:15:26 CET | Press release
DC Secretary Announces Annual Determinations Committees Outcome
CA-HTEC/G2-RISK28.3.2024 17:03:32 CET | Press release
Faster Recoveries, Improved Security: HTEC and G2 Risk Solutions Join Forces to Advance Bankruptcy Management
YCVB28.3.2024 16:01:31 CET | Press release
The reopening of the Yokohama Museum of Art adds another innovative and distinctive venue for events in Yokohama
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom